| Renal denervation for the treatment of resistant hypertension: review and clinical perspective R Iliescu, TE Lohmeier, I Tudorancea, L Laffin, GL Bakris American Journal of Physiology-Renal Physiology 309 (7), F583-F594, 2015 | 62 | 2015 |
| Chronic baroreflex activation restores spontaneous baroreflex control and variability of heart rate in obesity-induced hypertension R Iliescu, I Tudorancea, ED Irwin, TE Lohmeier American Journal of Physiology-Heart and Circulatory Physiology 305 (7 …, 2013 | 50 | 2013 |
| Baroreflex activation: from mechanisms to therapy for cardiovascular disease R Iliescu, I Tudorancea, TE Lohmeier Current hypertension reports 16, 1-9, 2014 | 38 | 2014 |
| Chronic interactions between carotid baroreceptors and chemoreceptors in obesity hypertension TE Lohmeier, R Iliescu, I Tudorancea, R Cazan, AW Cates, ... Hypertension 68 (1), 227-235, 2016 | 27 | 2016 |
| Oxidative stress in arterial hypertension (HTN): The nuclear factor erythroid factor 2-related factor 2 (Nrf2) pathway, implications and future perspectives DM Tanase, AG Apostol, CF Costea, CC Tarniceriu, I Tudorancea, ... Pharmaceutics 14 (3), 534, 2022 | 17 | 2022 |
| Ibuprofen-loaded chitosan/poly (maleic anhydride-alt-vinyl acetate) submicronic capsules for pain treatment DM Iurea, M Popa, JF Chailan, BI Tamba, I Tudorancea, CA Peptu Journal of Bioactive and Compatible Polymers 28 (4), 368-384, 2013 | 13 | 2013 |
| MicroRNAs (miRNAs) in cardiovascular complications of rheumatoid arthritis (RA): what is new? DM Tanase, EM Gosav, D Petrov, DS Teodorescu, ON Buliga-Finis, ... International Journal of Molecular Sciences 23 (9), 5254, 2022 | 12 | 2022 |
| Brugada syndrome: From molecular mechanisms and genetics to risk stratification IP Popa, DN Șerban, MA Mărănducă, IL Șerban, BI Tamba, I Tudorancea International Journal of Molecular Sciences 24 (4), 3328, 2023 | 11 | 2023 |
| Reduced renal mass, salt-sensitive hypertension is resistant to renal denervation I Tudorancea, TE Lohmeier, BT Alexander, D Pieptu, DN Serban, ... Frontiers in Physiology 9, 455, 2018 | 10 | 2018 |
| Contribution of oxidative stress (OS) in calcific aortic valve disease (CAVD): From pathophysiology to therapeutic targets DM Tanase, E Valasciuc, EM Gosav, M Floria, CF Costea, N Dima, ... Cells 11 (17), 2663, 2022 | 9 | 2022 |
| Nanomaterial-based drug targeted therapy for cardiovascular diseases: ischemic heart failure and atherosclerosis MȘC Haba, DN Șerban, L Șerban, IM Tudorancea, RM Haba, O Mitu, ... Crystals 11 (10), 1172, 2021 | 9 | 2021 |
| The therapeutic potential of the endocannabinoid system in age-related diseases IM Tudorancea, M Ciorpac, GD Stanciu, C Caratașu, A Săcărescu, ... Biomedicines 10 (10), 2492, 2022 | 8 | 2022 |
| Collagen-binding nanoparticles: a scoping review of methods and outcomes CE Roată, Ș Iacob, Ș Morărașu, C Livadaru, I Tudorancea, S Luncă, ... Crystals 11 (11), 1396, 2021 | 7 | 2021 |
| Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry M Kerneis, F Cosentino, R Ferrari, JL Georges, E Kosmachova, ... European journal of preventive cardiology 29 (15), 1945-1954, 2022 | 6 | 2022 |
| Tumor-facing hepatocytes significantly contribute to mild hyperthermia-induced targeting of rat liver metastasis by PLGA-NPs C Castellani, M Fedrigo, R Tavano, R Cappellini, C Fedeli, M Mognato, ... International Journal of Pharmaceutics 566, 541-548, 2019 | 6 | 2019 |
| New experimental model for single liver lobe hyperthermia in small animals using non-directional microwaves I Tudorancea, V Porumb, A Trandabăţ, D Neaga, B Tamba, R Iliescu, ... Plos one 12 (9), e0184810, 2017 | 5 | 2017 |
| The RAAS axis and SARS-CoV-2: from oral to systemic manifestations MA Maranduca, CG Vamesu, DM Tanase, A Clim, IC Drochioi, ... Medicina 58 (12), 1717, 2022 | 4 | 2022 |
| The ESC-EORP Chronic Ischaemic Cardiovascular Disease Long Term (CICD LT) registry M Komajda, F Cosentino, R Ferrari, C Laroche, A Maggioni, PG Steg, ... European Heart Journal-Quality of Care and Clinical Outcomes 7 (1), 28-33, 2021 | 4 | 2021 |
| Intracerebroventricular coadministration of Protoxin-II and trace elements in rats enhances the analgesic effect of the 1.7 voltage-gate sodium channel blocker GD Stanciu, A Luca, A Marza, T Alexa-Stratulat, I Tudorancea, W Bild, ... BioMed Research International 2019, 2019 | 4 | 2019 |
| A non-conventional approach to 10-year-delayed extraction of pacemaker leads associated with recurrent infective complications AM Ignat, D Corduneanu, AO Petris, I Tudorancea The Anatolian Journal of Cardiology 18 (4), 311, 2017 | 4 | 2017 |
